ArticleThe Lancet. Global health2025
The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study.
Nuri Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it